Kodiak Sciences KOD
NASDAQ KOD
$35.36 -1.00 (-2.75%)
As of: Sep 4, 2026 · 3:59 PM EDT

Kodiak Sciences (KOD) Amortizatization of Intangibles (2019 - 2026)

Kodiak Sciences' (KOD) quarterly Amortizatization of Intangibles came in at $328000.0 in Q2 2023, up 4.46% YoY from $314000.0 in Q2 2022, and down 36.68% on a QoQ basis from $518000.0 in Q1 2023.

Analysis

Kodiak Sciences (KOD) Amortizatization of Intangibles (2019 - 2026) Analysis & Trends

Kodiak Sciences (KOD) has 5 years of Amortizatization of Intangibles data on file, last reported at $328000.0 in Q2 2023.

  • Quarterly Amortizatization of Intangibles rose 4.46% year-over-year to $328000.0 in Q2 2023, while the trailing twelve-month figure through Mar 2024 was $328000.0 (down 79.32% YoY) and the FY2023 annual result came in at $846000.0, down 20.79% from the prior year.
  • Amortizatization of Intangibles fell to $328000.0 in Q2 2023, from $518000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $518000.0 in Q1 2023 to a low of -$356000.0 in Q2 2020.
  • A 5-year average of $145400.0 and a median of $100000.0 in 2019 frame the typical range for Amortizatization of Intangibles.
  • Annual changes were most pronounced in 2020 — Amortizatization of Intangibles slumped 456.0% — and 2022, when it soared 5333.33%.
  • Tracing KOD's Amortizatization of Intangibles over 5 years: stood at $46000.0 in 2019, then tumbled by 304.35% to -$94000.0 in 2020, then jumped by 93.62% to -$6000.0 in 2021, then jumped by 5433.33% to $320000.0 in 2022, then increased by 2.5% to $328000.0 in 2023.
  • The last three Amortizatization of Intangibles figures came in at $328000.0 (Q2 2023), $518000.0 (Q1 2023), and $320000.0 (Q4 2022), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 4.33 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 678,000.00
10 Kodiak Sciences 2.21 Bn 2.21 Bn - 2.08 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.08 Mn
Mar 31, 2026 2.23 Mn
Dec 31, 2025 1.97 Mn
Sep 30, 2025 1.95 Mn
Jun 30, 2025 1.94 Mn
Mar 31, 2025 2.13 Mn
Dec 31, 2024 2.06 Mn
Sep 30, 2024 2.01 Mn
Jun 30, 2024 1.99 Mn
Mar 31, 2024 1.94 Mn
Dec 31, 2023 1.94 Mn
Sep 30, 2023 1.97 Mn
Jun 30, 2023 1.90 Mn
Mar 31, 2023 1.85 Mn
Dec 31, 2022 1.75 Mn
Sep 30, 2022 1.72 Mn
Jun 30, 2022 1.84 Mn
Mar 31, 2022 1.90 Mn
Dec 31, 2021 1.90 Mn
Sep 30, 2021 1.91 Mn